FSD Pharma Inc. (HUGE): Price and Financial Metrics

FSD Pharma Inc. (HUGE): $1.18

0.08 (-6.35%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

HUGE Price/Volume Stats

Current price $1.18 52-week high $2.10
Prev. close $1.26 52-week low $0.62
Day low $1.14 Volume 131,200
Day high $1.28 Avg. volume 150,684
50-day MA $1.16 Dividend yield N/A
200-day MA $1.30 Market Cap 46.07M

HUGE Stock Price Chart Interactive Chart >


FSD Pharma Inc. (HUGE) Company Bio


FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.


HUGE Latest News Stream


Event/Time News Detail
Loading, please wait...

HUGE Latest Social Stream


Loading social stream, please wait...

View Full HUGE Social Stream

Latest HUGE News From Around the Web

Below are the latest news stories about FSD PHARMA INC that investors may wish to consider to help them evaluate HUGE as an investment opportunity.

FSD Pharma Inc. Securityholders Approve Plan of Arrangement with Celly Nutrition Corp.

TORONTO, ON / ACCESSWIRE / November 21, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased ...

Yahoo | November 21, 2023

FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of Arrangement

TORONTO, ON / ACCESSWIRE / November 17, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased ...

Yahoo | November 17, 2023

FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023

TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to ...

Yahoo | November 15, 2023

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis

TORONTO, ON / ACCESSWIRE / November 7, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to ...

Yahoo | November 7, 2023

FSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus

TORONTO, ON / ACCESSWIRE / November 6, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to ...

Yahoo | November 6, 2023

Read More 'HUGE' Stories Here

HUGE Price Returns

1-mo 19.19%
3-mo -8.53%
6-mo -3.28%
1-year 32.93%
3-year -23.87%
5-year -98.04%
YTD 49.67%
2022 -22.71%
2021 -34.62%
2020 -71.26%
2019 -87.37%
2018 755.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!